Table 1.
Clinical trials of PRP for TE
| Author | Study design | Cut-off value of thin endometrium | Sample size | EMT of control group (mm) | EMT of PRP group (mm) | P value | P value | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Control | PRP | Chemical pregnancy | Clinical pregnancy | Ongoing pregnancy | ||||||
| Eftekhar et al. 2018 [20] | RCT | <7 mm | 43 | 40 | 8.04 ± 0.27 | 8.67 ± 0.64 | 0.001 | 0.091 | 0.044 | 0.127 |
| Nazari et al. 2019 [34] | Double-blind RCT | <7 mm | 30 | 30 | 5.76 ± 0.97 | 7.21 ± 0.18 | <0.001 | 0.031 | 0.048 | / |
| Chang et al. 2019 [29] | NRCT | <7 mm | 30 | 34 | 6.52 ± 0.31 | 7.65 ± 0.22 | 0.013 | / | 0.036 | / |
| Author | Study design | Cut-off value of thin endometrium | Sample size |
EMT of prior to intervention (mm) |
EMT of post to intervention (mm) |
P value |
Chemical pregnancy Rate(%) |
Clinical pregnancy Rate(%) |
Live birth Rate(%) |
|
| Molina et al. 2018 [35] | Prospective cohort | * | 19 | / | >9 mm | / | 10.5 | / | 26.3 | |
| Kim et al. 2019[36] | Prospective cohort | <7 mm | 20 | 5.4 ± 0.8 | 6.0 ± 1.1 | 0.07 | / | 30.0 | 20.0 | |
| Chang et al. 2015 [19] | Cohort | <7 mm | 5 | 5.9–6.6 | ≥7.0 | / | 20.0 | 80.0 | / | |
| Nazari et al. 2017 [37] | Cohort | <7 mm | 10 | 4.0–6.0 | 7.1–7.5 | / | 50.0 | 25.0 | / | |
| Tandulwadkar et al. 2017 [38] | Cohort | <7 mm | 68 | Average 5 | Average 7.22 | <0.00001 | 29.4 | 38.2 | / | |
| Wang et al. 2018 [24] | Cohort | <7 mm | 20 | 5.55 ± 0.71 | 7.82 ± 1.04 | <0.0001 | / | 60.0 | / | |
| Agarwal et al. 2020 [39] | Cohort | <7 mm | 32 | / | / | / | 41.6 | 8.3 | 20.8 | |
| Kusumi et al. 2020 [40] | Cohort | <7 mm | 36 | 5.86 ± 0.95 | 7.13 ± 0.89 | / | 18.8 | 15.6 | / | |